Uroguanylin, human 2.5 mg | ≥95% LKT Laboratories, Inc. Endogenous peptide, involved in water/Na+ homeostasis; GC-C agonist. More Information Supplier Page × Uroguanylin, human
Uroguanylin, human 1 mg | ≥95% LKT Laboratories, Inc. Endogenous peptide, involved in water/Na+ homeostasis; GC-C agonist. More Information Supplier Page × Uroguanylin, human
Uroguanylin, human 0.5 mg | ≥95% LKT Laboratories, Inc. Endogenous peptide, involved in water/Na+ homeostasis; GC-C agonist. More Information Supplier Page × Uroguanylin, human
Urotensin I 2.5 mg | ≥95% LKT Laboratories, Inc. Endogenous peptide, involved in stress signaling; CRF1/2 agonist. More Information Supplier Page × Urotensin I
Urotensin I 1 mg | ≥95% LKT Laboratories, Inc. Endogenous peptide, involved in stress signaling; CRF1/2 agonist. More Information Supplier Page × Urotensin I
[Lys8]-Vasopressin 2 mg | ≥95% LKT Laboratories, Inc. Peptide, vasopressin analog; V1/2 agonist. More Information Supplier Page × [Lys8]-Vasopressin
[Lys8]-Vasopressin 1 mg | ≥95% LKT Laboratories, Inc. Peptide, vasopressin analog; V1/2 agonist. More Information Supplier Page × [Lys8]-Vasopressin
[Arg8]-Vasotocin 5 mg | ≥95% LKT Laboratories, Inc. Peptide, oxytocin-vasopressin analog. More Information Supplier Page × [Arg8]-Vasotocin
[Arg8]-Vasotocin 2 mg | ≥95% LKT Laboratories, Inc. Peptide, oxytocin-vasopressin analog. More Information Supplier Page × [Arg8]-Vasotocin
[Arg8]-Vasotocin 1 mg | ≥95% LKT Laboratories, Inc. Peptide, oxytocin-vasopressin analog. More Information Supplier Page × [Arg8]-Vasotocin
